KARO HEALTHCARE
LIVE

Serial Number

99378139

Owner

Karo Healthcare AB

Attorney

Clifford D Hyra

Filing Date

Sep 5, 2025

Add to watchlist:

No watchlists yet
View on USPTO

KARO HEALTHCARE Trademark

Serial Number: 99378139

KARO HEALTHCARE is a trademark filed by Karo Healthcare AB on September 5, 2025. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Karo Healthcare AB

Box 16184
Stockholm 103 24 , SE

Entity Type: 64

Trademark Details

Filing Date

September 5, 2025

Registration Date

Not Registered

Goods & Services

Bleaching preparations for laundry use; Cleaning preparations; Polishing preparations; Cleaning, scouring and polishing preparations and substances; Flexible abrasives; Non-medicated soaps; Perfumery; Ethereal oils; Cosmetics; Hair lotions; Non-medicated dentifrices; Breath freshening sprays; Non-medicated mouth rinse; Non-medicated mouth washes; Dental bleaching gels; Cosmetic preparations for the care of mouth and teeth; Lotions for face and body care; Non-medicated cosmetics; Non-medicated toiletry preparations; Non-medicated hair care preparations; Non-medicated body care preparations; Nail care preparations; Non-medicated foot cream; Hand cleansers; Hand masks for skin care; Deodorant for personal use; Shaving preparations; Aftershave preparations; Sunscreen

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Dermatological pharmaceutical products; Pharmaceutical skin lotions; Pharmaceutical preparations for the treatment of hyperhidrosis; Sanitary preparations for medical purposes; Diagnostic agents for pharmaceutical purposes; Sunburn preparations for pharmaceutical purposes; Effervescent analgesic pharmaceutical preparations; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for treating dandruff; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for use in discouraging the smoking habit; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for wounds; Pharmaceuticals, namely, anti-infectives; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical antitussive-cold preparations; Cardiovascular pharmaceuticals; Antibacterial pharmaceuticals; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Digestives for pharmaceutical purposes; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Balms for pharmaceutical purposes; Medical cleansers for skin and wounds; Medicated skin care preparations; Pharmaceutical preparations for skin care; Veterinary preparations, namely, pain relief medication; Veterinary preparations for treatment of intestinal bacteria; Bacteriological preparations for veterinary purposes; Dietetic preparations adapted for medical purposes; Disinfectants; Vitamin preparations; Vulnerary sponges; Medicated mouth care preparations; Fungicides; Herbicides; Vaccines

Advertising and marketing; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Business administration; Secretarial and clerical services; Providing consumer product information relating to cosmetics

Apparatus for acne treatment; Apparatus for administering inhalants for medical purposes; Ultrasound apparatus for medical use; Surgical and medical apparatus for use in general and orthopedic surgery; Jade rollers in the nature of a massage apparatus; Apparatus for testing breast milk for medical purposes; Ultrasound apparatus for veterinary use; Manually-operated exercise equipment for physical therapy purposes; Body rehabilitation apparatus for medical purposes; Surgical apparatus and instruments; Medical devices and apparatus, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical instruments, namely, orthopedic apparatus and instruments; Orthopedic supports; Knee bandages, orthopaedic; Orthopedic soles; Intubation boxes for medical purposes

Clinical surgery research; Scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing of cosmetics; Laboratory research in the field of cosmetics; Biochemical research and development services; Compiling data for research purposes in the field of medical science and medical consultancy

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 26, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
May 26, 2026 GNSL
SUSPENSION LETTER WRITTEN
May 26, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 23, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 28, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 28, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 28, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 28, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 5, 2025 MAFR
NEW APPLICATION ENTERED
Sep 5, 2025 NWAP